Taysha Gene Therapies, Inc. (TSHA) earnings
TSHA earnings moved a median of +2.22% by the close. Quarterly and annual TSHA reports and results, each read against the price at its own news timestamp. Back to the TSHA overview →
30 measured TSHA earnings events.
Where these TSHA earnings landedvs 28 measured TSHA earnings reactions
| Middle 50% of TSHA earnings reactions | -0.12% to +6.80% |
|---|---|
| Median reaction (to close) | +2.22% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 TSHA earnings events with a measured close landed between -0.12% and +6.80%; 71% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Taysha Gene Therapies, For: Jun 30 | SEC filing · Form 10-Q | +1.98% | +5.87% | |
| Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | +1.98% | +5.87% | |
| Taysha Gene Therapies to Release Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 11 | Press release | +0.08% | +2.70% | |
| Form 10-Q Taysha Gene Therapies, For: Mar 31 | SEC filing · Form 10-Q | +0.08% | +5.60% | |
| Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | +0.08% | +5.60% | |
| Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6 | Press release | +0.80% | +0.32% | |
| Form 10-K Taysha Gene Therapies, For: Dec 31 | SEC filing · Form 10-K | -3.52% | +0.22% | |
| Form 10-Q Taysha Gene Therapies, For: Sep 30 | SEC filing · Form 10-Q | -6.29% | -0.47% | |
| Taysha Gene Therapies Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | -6.29% | -0.47% | |
| Taysha Gene Therapies to Release Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 4 | Press release | +2.66% | +2.04% | |
| Form 10-Q Taysha Gene Therapies, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | — | |
| Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | -1.51% | — | |
| Taysha Gene Therapies to Release Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 12 | Press release | -1.81% | +1.09% | |
| Form 10-Q Taysha Gene Therapies, For: Mar 31 | SEC filing · Form 10-Q | +5.00% | +2.40% | |
| Taysha Gene Therapies Reports First Quarter 2025 Financial Results and Provides Corporate Update | Press release | +5.00% | +2.40% | |
| Taysha Gene Therapies to Release First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15 | Press release | +2.39% | +1.91% | |
| Form 10-K Taysha Gene Therapies, For: Dec 31 | SEC filing · Form 10-K | -6.11% | -10.00% | |
| Form 10-Q Taysha Gene Therapies, For: Sep 30 | SEC filing · Form 10-Q | +14.22% | +11.28% | |
| Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | +14.22% | +11.28% | |
| Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13 | Press release | +8.40% | +9.60% | |
| Form 10-Q Taysha Gene Therapies, For: Jun 30 | SEC filing · Form 10-Q | +1.40% | -4.67% | |
| Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | +1.40% | -4.67% | |
| Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12 | Press release | -1.01% | +2.02% | |
| Form 10-Q Taysha Gene Therapies, For: Mar 31 | SEC filing · Form 10-Q | +4.40% | +24.40% | |
| Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update | Press release | +4.40% | +24.40% | |
| Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14 | Press release | -1.61% | -4.03% | |
| Form 10-K Taysha Gene Therapies, For: Dec 31 | SEC filing · Form 10-K | -1.70% | +0.00% | |
| Form 10-Q Taysha Gene Therapies, For: Sep 30 | SEC filing · Form 10-Q | +16.67% | +12.00% | |
| Taysha Gene Therapies Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates | Press release | +16.67% | +12.00% | |
| Taysha Gene Therapies to Release Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 14 | Press release | +0.00% | -1.22% |
Keep exploring
More TSHA: analyst actions → · SEC filings → · TSHA overview →